Skip to main

Rx GHK-Cu · Getting better

Thirteen people, two answers about GHK-Cu

A small GHK-Cu study gave me two answers: greater satisfaction and no significant difference in measured redness. I think that split deserves more attention than another list of benefits.

An oval hand mirror faces a colour measuring instrument and rose calibration tiles on a pale clay table

Laser resurfacing

In a randomized trial of 13 people after CO2 laser resurfacing, a topical copper tripeptide complex produced no statistically significant objective difference in erythema, the redness of recovering skin, compared with control. Satisfaction was significantly higher in the GHK-Cu group, with p=0.04.

A visible reduction in redness would have made an uncomplicated recovery story. The satisfaction finding sent the question somewhere less tidy. People preferred an outcome that the redness measurement did not distinguish. That gives the study a peculiar usefulness: it leaves both the person's judgment and the measured skin response on the page.

To me, satisfaction deserves a place in a recovery study. So does the unresolved redness result. With 13 participants, this experiment leaves considerable uncertainty; it establishes neither faster recovery nor an explanation for why satisfaction differed. I'd welcome a larger repeat that measured those outcomes together.

Redness, satisfaction and study size

Greater satisfaction and a statistically unremarkable redness comparison can coexist. Calling both simply ‘better skin’ loses the most interesting thing about this study.

A technician compares muted rose ceramic tiles inside a daylight colour assessment booth
An imagined colour-assessment scene. The tiles illustrate the work of comparing colour; this is not the trial or its participants.

GHK copper peptide

GHK-Cu combines copper with GHK, a peptide made from glycine, histidine and lysine. The history starts with GHK isolated from human plasma in 1973: added to aged liver tissue in the laboratory, it prompted protein synthesis resembling younger tissue. The skin-care history came later.

That origin makes the repair story plausible to me, though the journey between a tissue experiment and a useful treatment remains substantial. GHK-Cu appears on cosmetic ingredient lists as Copper Tripeptide-1. Its copper binding and effects on tissue-building cells explain why it attracts interest; how copper peptides work follows those experiments more closely.

Copper peptide benefits, counted separately

The small human skin studies collected in a skin-regeneration review report changes in collagen production, firmness and wrinkles. Each names something more specific than rejuvenation. A controlled hair study counted hairs after a preparation containing GHK and another active ingredient. Wound experiments often measured closure in animals.

I trust the smaller nouns here: redness, satisfaction, collagen, hair count, wound closure. Each gives an experiment a definite task. Combining them under ‘recovery’ creates a much bigger claim than any of those measurements can carry alone. The research pages put the actual outcomes back into their respective settings.

The recovery question

Rx suggests the hope of a remedy. For GHK-Cu, I want that hope to end in a clear description of the change someone is seeking. A laboratory number offers little help with that particular question.

The same curiosity extends to reported benefits and side effects, where the experiences are anecdotal accounts rather than clinical evidence. For study amounts and the very different question of systemic exposure, there is a separate doses and routes page. GHK-Cu has no FDA- or EMA-approved therapeutic indication; its established cosmetic use concerns topical Copper Tripeptide-1.